Winstrol (Stanozolol – Oily solution) Euro-Pharmacies: Compound Profile
Stanozolol (Winstrol) is a synthetic anabolic androgenic steroid derived from dihydrotestosterone, formulated by Euro-Pharmacies as an oily injection solution for laboratory research applications. This compound exhibits unique structural modifications that distinguish it from its parent hormone, including a pyrazole ring attachment at the A-ring position. Researchers at Stroid UK Shop can investigate stanozolol’s distinctive binding properties and molecular interactions in controlled laboratory environments. The oily vehicle formulation enables extended tissue distribution studies and provides researchers with an alternative delivery system compared to oral preparations commonly found in our steroid injection collection.
Research Applications
Laboratory studies examine stanozolol’s interaction with androgen receptors and its effects on protein synthesis pathways in cellular models. Research protocols investigate the compound’s influence on nitrogen retention mechanisms and collagen synthesis in tissue culture systems. Scientists analyse stanozolol’s hepatic metabolism patterns and its conversion through various enzymatic pathways in liver cell studies. The injectable formulation allows researchers to study bioavailability profiles and tissue distribution kinetics in experimental models. Comparative research evaluates stanozolol against other anabolic compounds available in our SARMS research section and peptide research collection. Molecular biology studies focus on stanozolol’s effects on gene expression related to muscle protein synthesis and degradation pathways.
Technical Specifications
| Parameter | Value |
|---|---|
| Chemical Name | 17α-methyl-5α-androst-2-eno[3,2-c]pyrazol-17β-ol |
| CAS Number | 10418-03-8 |
| Molecular Formula | C₂₁H₃₂N₂O |
| Molecular Weight | 328.49 g/mol |
| Formulation | Oily injection solution |
| Manufacturer | Euro-Pharmacies |
| Storage | Room temperature, protect from light |
| Solubility | Oil-based vehicle |
Research Compliance
This stanozolol injection solution is manufactured exclusively for in-vitro laboratory research purposes and cellular studies. Euro-Pharmacies produces this compound under research-grade standards for scientific investigation only. All studies must comply with appropriate laboratory safety protocols and institutional research guidelines. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers should consult relevant regulatory frameworks and maintain proper documentation for all experimental procedures involving this research chemical.
